Compare
Natera vs Thermo Fisher Scientific
MonkScore ranges and fundamentals, side by side
Key facts
Natera and Thermo Fisher Scientific: key facts
- In fiscal 2025, Natera, Inc. reported revenue of $2.3B and net income of -$208.2M.
- In fiscal 2025, Thermo Fisher Scientific Inc. reported revenue of $44.6B and net income of $6.7B.
- Natera, Inc.'s revenue grew 38.6% a year from fiscal 2021 to fiscal 2025.
- Thermo Fisher Scientific Inc.'s revenue grew 3.2% a year from fiscal 2021 to fiscal 2025.
- Natera, Inc.'s free cash flow was positive in 2 of the 5 fiscal years from 2021 to 2025.
- Thermo Fisher Scientific Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- In the twelve months to 30 June 2026, Natera, Inc. reported revenue of $2.7B and net income of -$192.3M.
- In the twelve months to 26 September 2026, Thermo Fisher Scientific Inc. reported revenue of $47.4B and net income of $7.1B.
Side by side
Natera and Thermo Fisher Scientific, side by side
Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.
| Figure | Natera, Inc.NASDAQ:NTRA | Thermo Fisher Scientific Inc.NYSE:TMO |
|---|---|---|
| MonkScore | ||
| MonkScore range | 70–80as of October 2026 | 60–70as of October 2026 |
| Sector rank | 208 of 628 in Healthcare | 252 of 628 in Healthcare |
| How this score is madeDisclaimer | ||
| Profile | ||
| Sector | Healthcare | Healthcare |
| Industry | Medical - Diagnostics & Research | Medical - Diagnostics & Research |
| Latest fiscal year | ||
| Revenue | $2.3BFY 2025 | $44.6BFY 2025 |
| Net income | -$208.2MFY 2025 | $6.7BFY 2025 |
| Free cash flow | $109.1MFY 2025 | $6.3BFY 2025 |
| Operating cash flow | $215.3MFY 2025 | $7.8BFY 2025 |
| Total debt | $214.4MFY 2025 | $39.4BFY 2025 |
| Cash | $1.1BFY 2025 | $9.9BFY 2025 |
| Last 12 months | ||
| Revenue | $2.7Bto 30 June 2026 | $47.4Bto 26 September 2026 |
| Net income | -$192.3Mto 30 June 2026 | $7.1Bto 26 September 2026 |
| Free cash flow | $71.7Mto 30 June 2026 | $7.6Bto 26 September 2026 |
| Operating cash flow | $228.2Mto 30 June 2026 | $9.3Bto 26 September 2026 |
| Total debt | $238.5Mto 30 June 2026 | $41.4Bto 26 September 2026 |
| Cash | $1.1Bto 30 June 2026 | $5.5Bto 26 September 2026 |
Company pages
Each company on its own
MonkStreet provides research, not investment advice.